These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 17512836)
1. Ovarian cancer and HRT in the Million Women Study. Narod SA Lancet; 2007 May; 369(9574):1667-8. PubMed ID: 17512836 [No Abstract] [Full Text] [Related]
2. Ovarian cancer and hormone replacement therapy in the Million Women Study. Beral V; ; Bull D; Green J; Reeves G Lancet; 2007 May; 369(9574):1703-10. PubMed ID: 17512855 [TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer and hormone replacement therapy. Gompel A; Plu-Bureau G Lancet; 2007 Sep; 370(9591):932; author reply 932-3. PubMed ID: 17869627 [No Abstract] [Full Text] [Related]
4. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated]. Emons G; Westphalen S MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648 [TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and risk of epithelial ovarian cancer. Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786 [TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer and menopausal hormone therapy: more data and new questions. Lacey JV Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2524-5. PubMed ID: 18086754 [No Abstract] [Full Text] [Related]
7. Long-term use of estrogen-only hormone replacement therapy (HRT) linked with increased risk of ovarian cancer. American Medical Association Ginecol Obstet Mex; 2002 Aug; 70():409-10. PubMed ID: 12448047 [No Abstract] [Full Text] [Related]
8. [Cancer caused by menopausal hormone substitution in Germany. Results of calculating the attributed risk]. Greiser E Kinderkrankenschwester; 2004 Apr; 23(4):146-7. PubMed ID: 16134648 [No Abstract] [Full Text] [Related]
9. HRT associated with modest risk increase in a relatively rare but serious cancer. Brown S Post Reprod Health; 2015 Mar; 21(1):7. PubMed ID: 26029754 [No Abstract] [Full Text] [Related]
12. An analysis of ovarian cancer in the Million Women Study. Neves-E-Castro M Gynecol Endocrinol; 2007 Jul; 23(7):410-3. PubMed ID: 17701773 [TBL] [Abstract][Full Text] [Related]
13. Menopausal hormones and risk of ovarian cancer. Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062 [TBL] [Abstract][Full Text] [Related]
14. The changing view of hormone replacement therapy. Vogel RA Rev Cardiovasc Med; 2003; 4(2):68-71. PubMed ID: 12776015 [TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer patients and hormone replacement therapy: a systematic review. Hopkins ML; Fung MF; Le T; Shorr R Gynecol Oncol; 2004 Mar; 92(3):827-32. PubMed ID: 14984948 [TBL] [Abstract][Full Text] [Related]
16. [Hormone replacement therapy: curse or blessing?]. Schmidt M; Fink D; Lang U; Kimmig R Gynakol Geburtshilfliche Rundsch; 2006; 46(4):165. PubMed ID: 17068400 [TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and the increase in the incidence of invasive lobular cancer. Ravdin PM Breast Dis; 2008-2009; 30():3-8. PubMed ID: 19850989 [TBL] [Abstract][Full Text] [Related]
18. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Beral V; Banks E; Reeves G Lancet; 2002 Sep; 360(9337):942-4. PubMed ID: 12354487 [TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and cancer: an update. La Vecchia C; Franceschi S Eur J Cancer Prev; 2003 Feb; 12(1):3-4. PubMed ID: 12548104 [No Abstract] [Full Text] [Related]
20. Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk. Mills PK; Riordan DG; Cress RD; Goldsmith DF Cancer Detect Prev; 2005; 29(2):124-32. PubMed ID: 15829372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]